<DOC>
	<DOCNO>NCT02962635</DOCNO>
	<brief_summary>A precise volume status assessment critical improve outcome patient dialysis . Yet , accurate assessment fluid status remain challenge . Currently , perform clinical evaluation regular weight measurement dialysis , always accurate . Moreover , bioimpedance technology use center quantitative assessment total body water . This approach validate assessment volume status dialysis patient , require acquisition specific tool time consume . So far , biomarker validate quantify volume status dialysis patient . Application biomarkers might contribute good dialysis prescription therefore outcome improvement dialysis . The investigator aim investigate role novel biomarkers ( sCD146 ) ass volume status dialysis patient</brief_summary>
	<brief_title>Role Biomarkers Patients Undergoing Dialysis Treatment</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 year old Patient dialysis since &gt; 1 month Voluntarily sign informed consent Pregnant breastfeed woman woman plan get pregnant study Incapability follow study protocol Acute illness Hospitalizations last week inclusion Cardiac pacemaker defibrillator Limb amputation factor preclude reliable bioimpedance measurement ( unreliable bioimpedance measurement )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>